Transcriptional repressors: multifaceted regulators of gene expression.

Development

Wellcome Trust - Medical Research Council Stem Cell Institute, Department of Biochemistry, University of Cambridge, Cambridge CB2 1QR UK.

Published: February 2013

AI Article Synopsis

  • Research over decades has shown that some chromatin-modifying proteins, known as 'repressors,' can inhibit transcription, but they are also found at actively transcribed genes.
  • Genome-wide studies indicate that the presence of these repressors at active loci is common, suggesting a more complex role in regulating gene expression.
  • The authors argue that these repressors can fine-tune transcription levels, playing a crucial role in development.

Article Abstract

Through decades of research it has been established that some chromatin-modifying proteins can repress transcription, and thus are generally termed 'repressors'. Although classic repressors undoubtedly silence transcription, genome-wide studies have shown that many repressors are associated with actively transcribed loci and that this is a widespread phenomenon. Here, we review the evidence for the presence of repressors at actively transcribed regions and assess what roles they might be playing. We propose that the modulation of expression levels by chromatin-modifying, co-repressor complexes provides transcriptional fine-tuning that drives development.

Download full-text PDF

Source
http://dx.doi.org/10.1242/dev.083105DOI Listing

Publication Analysis

Top Keywords

actively transcribed
8
transcriptional repressors
4
repressors multifaceted
4
multifaceted regulators
4
regulators gene
4
gene expression
4
expression decades
4
decades established
4
established chromatin-modifying
4
chromatin-modifying proteins
4

Similar Publications

Introduction Debriefing in healthcare simulation is helpful in reinforcing learning objectives, closing performance gaps, and improving future practice and patient care. The Debriefing Assessment for Simulation in Healthcare (DASH) is a validated tool. However, localized rater training for the DASH has not been described.

View Article and Find Full Text PDF

Background: Interactive electronic devices (IEDs) are ubiquitous in young children's lives. However, research on their impact on learning and development is still limited. The aim of this study was to understand the perspectives of early years practitioners (EYPs) and public health consultants (PHCs) on the use of IEDs in children aged 3-5.

View Article and Find Full Text PDF

Evolving Roles: Adolescent perspectives on shared decision making with their parents and healthcare providers.

Acad Pediatr

January 2025

James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. Electronic address:

Introduction: Shared decision making (SDM) involving adolescents presents unique challenges. To adequately support and evaluate SDM that includes adolescents, parents, and healthcare providers, it is imperative to understand adolescent perspectives. This study aims to describe the perspectives of adolescents with chronic health conditions regarding sharing medical decisions with their parents and healthcare providers.

View Article and Find Full Text PDF

Purpose: The purpose of the study was to explore the facilitators and barriers of health behaviors in patients with type 2 diabetes (T2D), providing a reference for the development of health behavior interventions programs.

Methods: A qualitative descriptive research design was adopted, and interviews were conducted with 25 patients with T2D. The interview guide was developed based on the health action process approach theory.

View Article and Find Full Text PDF

MicroRNA (miR)-126 is frequently downregulated in malignancies, including breast cancer (BC). Despite its tumor-suppressive role, the mechanisms underlying miR-126 deregulation in BC remain elusive. Through silencing experiments, we identified Early B Cell Factor 1 (EBF1), ETS Proto-Oncogene 2 (ETS2), and Krüppel-Like Factor 2 (KLF2) as pivotal regulators of miR-126 expression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!